In addition, anti‐AK5 limbic encephalitis patients more frequently exhibited ≥ 3 of the following symptoms compared to mimics (100% vs. 22.2%, p < 0.05): working memory deficits, new‐onset seizures, behavioral disorders, psychiatric symptoms, and sleep disorders. Here, AK5 is linked to sleep disorder.